Page results
-
UCLH will play a vital role in a new respiratory virus study.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
File results
-
FOI/2024/0627 - E-signature vendor supplier and cost
-
FOI/2024/0634 - Private Finance Initiative (PFI) and Private Finance 2 (PF2) projects repayments and debt
-
FOI201782 Maternity services
-
FOI201791 IVF treatment
-
FOI201788 Patient discharge
-
FOI/2024/0904 - Multiple Myeloma treatments
-
FOI201786 EU national staff leaving posts
-
FOI201785 Opthalmology treatments
-
FOI201784 Premature births
-
Patient diagnosis, referral, treatment for Essential Tremor/Deep Brain Stimulation/MR-guided Focused Ultrasound (MRgFUS)